Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APC^Min/+ Mouse Model of Intestinal Tumorigenesis

• Mark Paul-Clark ,

  ¶‡ These authors are joint first-authors.

  Affiliation Imperial College London, London, United Kingdom

  ⨯
• Wagdi Elsheikh ,

  ¶‡ These authors are joint first-authors.

  Affiliation Department of Medicine, McMaster University, Hamilton, Ontario, Canada

  ⨯
• Nicholas Kirkby,

  Affiliation Imperial College London, London, United Kingdom

  ⨯
• Melissa Chan,

  Affiliation William Harvey Research Institute, London, United Kingdom

  ⨯
• Pallavi Devchand,

  Affiliation Mount Sinai Hospital, Icahn Medical Institute, New York, United States of America

  ⨯
• Terence A. Agbor,

  Affiliation Department of Medicine, McMaster University, Hamilton, Ontario, Canada

  ⨯
• Kyle L. Flannigan,

  Affiliation Department of Medicine, McMaster University, Hamilton, Ontario, Canada

  ⨯
• Charlotte Cheadle,

  Affiliation Imperial College London, London, United Kingdom

  ⨯
• Maxim Freydin,

  Affiliation Imperial College London, London, United Kingdom

  ⨯
• Angela Ianaro,

  Affiliation Department of Experimental Pharmacology, Universita di Napoli Federico II, Napoli, Italy

  ⨯
• Jane A. Mitchell,

  Affiliation Imperial College London, London, United Kingdom

  ⨯
• John L. Wallace

  * E-mail: altapharm@hotmail.com

  Affiliations Department of Physiology & Pharmacology, University of Calgary, Calgary, Alberta, Canada, Faculty of Medicine, Universidade Camilo Castelo Branco, São Paulo, SP, Brazil

  ⨯